Carisma Therapeutics (CARM) Stock Chart & Stock Price History $0.86 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Carisma Therapeutics Stock Price Performance 5 Day Performance-2.36%1 Month Performance-11.77%3 Month Performance-31.01%6 Month Performance-39.27%Year-To-Date Performance-70.57%1 Year Performance-64.66% Receive CARM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide CARM Stock Chart for Thursday, November, 21, 2024 CARM Chart by TradingView Carisma Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$0.87$0.86-0.54%$0.87$0.8576,252 shs$36.01 million11/19/2024$0.88$0.87-0.90%$0.90$0.85117,163 shs$36.20 million11/18/2024$0.88$0.88-0.93%$0.91$0.87108,667 shs$36.53 million11/15/2024$0.94$0.88-5.93%$0.94$0.86238,636 shs$36.87 million11/14/2024$0.97$0.94-3.52%$0.99$0.93101,472 shs$39.20 million11/13/2024$1.00$0.97-2.19%$1.01$0.95141,586 shs$40.63 million Get the Latest News and Ratings for CARM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$1.00$1.00-0.16%$1.01$0.96189,825 shs$41.33 million11/11/2024$1.01$1.00-1.33%$1.01$0.96252,412 shs$41.40 million11/08/2024$1.03$1.01-1.94%$1.04$0.98850,018 shs$41.96 million11/07/2024$1.11$1.03-7.21%$1.09$1.03207,679 shs$42.79 million11/06/2024$1.10$1.11+0.91%$1.13$1.08189,519 shs$46.11 million11/05/2024$1.05$1.10+4.76%$1.10$1.05216,527 shs$45.69 million11/04/2024$1.00$1.05+5.00%$1.07$0.99161,026 shs$43.62 million11/01/2024$0.97$1.00+2.72%$1.02$0.99122,080 shs$41.54 million10/31/2024$1.00$0.97-2.65%$1.02$0.96130,297 shs$40.44 million10/30/2024$1.01$1.00-0.99%$1.09$1.00278,668 shs$41.55 million10/29/2024$1.00$1.01+1.28%$1.01$0.9898,738 shs$41.96 million10/28/2024$1.00$1.00-0.28%$1.03$0.99144,562 shs$41.42 million10/25/2024$1.00$1.00+0.22%$1.01$0.96123,067 shs$41.54 million10/24/2024$1.01$1.00-1.21%$1.02$0.9972,511 shs$41.45 million10/23/2024$0.98$1.01+3.06%$1.03$0.98106,832 shs$41.96 million10/22/2024$0.98$0.98+0.26%$1.00$0.95106,172 shs$40.71 million10/21/2024$0.97$0.98+0.28%$1.01$0.9579,621 shs$40.61 million Related Companies Cytosorbents Stock Price Chart TherapeuticsMD Stock Price Chart Sensei Biotherapeutics Stock Price Chart Aspira Women's Health Stock Price Chart Exagen Stock Price Chart Black Diamond Therapeutics Stock Price Chart Neoleukin Therapeutics Stock Price Chart Inventiva Stock Price Chart Acumen Pharmaceuticals Stock Price Chart Elutia Stock Price Chart Receive CARM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CARM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carisma Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
